CPNG Announcement: If You Have Suffered Losses in Coupang, Inc. (NYSE: CPNG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

(NYSE:CPNG), NEW YORK, Dec. 16, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Coupang, Inc. (NYSE: CPNG) resulting from allegations that Coupang may have issued materially misleading business information to the investing public. SO WHAT: If you […]

CPNG Announcement: If You Have Suffered Losses in Coupang, Inc. (NYSE: CPNG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

CPNG Announcement: If You Have Suffered Losses in Coupang, Inc. (NYSE: CPNG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire December 17, 2025 NEW YORK, Dec. 16, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf

ICAC Commissioner attends international anti-graft conference online while staying in Hong Kong to oversee corruption investigation

ICAC Commissioner Woo Ying-ming, in his capacity of President of the International Association of Anti-Corruption Authorities (IAACA), earlier attended the IAACA Annual Conference held in Doha, Qatar and delivered an opening remarks through video conferencing. https://mma.prnewswire.com/media/2846530/1.jpg Mr Woo was going to head a delegation to Doha to chair the IAACA Executive Committee meeting, attend the

ROSEN, TOP-RANKED INVESTOR RIGHTS COUNSEL, Encourages Skye Bioscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SKYE

NEW YORK CITY, NY / ACCESS Newswire / December 16, 2025 / WHY: New York, N.Y., December 16, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Skye Bioscience, Inc. (NASDAQ:SKYE) between November 4, 2024 and October 3, 2025, both dates inclusive (the "Class Period"), of the important January

Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

(NASDAQ:ANNX), BRISBANE, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) — Annexon, Inc. (“Annexon”) (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform targeting neuroinflammation across life-changing complement-mediated diseases of the body, brain, and eye, today announced that it has granted inducement to a new non-executive employee under the terms of the 2022 Employment Inducement Award

Aegis Living Offers Emergency & Respite Housing for Seniors Displaced by Washington State Flooding

As widespread flooding continues to impact communities across Washington State, Aegis Living has activated its emergency response protocol and is immediately offering respite placements for seniors who have been displaced or evacuated due to the storms. https://mma.prnewswire.com/media/540312/Aegis_no_tag_hi_res_imagev1.jpg Aegis Living communities across Washington currently have availability in both Assisted Living and Memory Care. Residents are accepted

Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire December 17, 2025 BRISBANE, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) — Annexon, Inc. (“Annexon”) (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform targeting neuroinflammation across life-changing complement-mediated diseases of the body, brain, and eye, today announced that it has granted

Aussie medtech Ferronova raises another $6 million to advance image-guided cancer surgery

Australian company Ferronova has raised a further $6 million to progress the commercialisation of a novel nanoparticle image-guided surgery solution seeking to improve identification of cancer cells and reduce the risk of undetected recurrence following surgery. Ferronova's super-paramagnetic iron oxide nanoparticles bind to cells found in lymph nodes which aim to enable identification of tissue

Aussie medtech Ferronova raises another $6 million to advance image-guided cancer surgery

Australian company Ferronova has raised a further $6 million to progress the commercialisation of a novel nanoparticle image-guided surgery solution seeking to improve identification of cancer cells and reduce the risk of undetected recurrence following surgery. Ferronova's super-paramagnetic iron oxide nanoparticles bind to cells found in lymph nodes which aim to enable identification of tissue

Scroll to Top